Location History:
- Kawasaki, JP (1999 - 2003)
- Tokyo, JP (1992 - 2010)
- Kanagawa, JP (2013 - 2015)
- Kawaski, JP (2019)
Company Filing History:
Years Active: 1992-2019
Title: Innovations of Toshiyuki Konosu
Introduction
Toshiyuki Konosu is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. With a total of 15 patents to his name, Konosu's work addresses critical challenges in combating bacterial infections.
Latest Patents
One of Konosu's latest patents focuses on Hydroxyalkyl thiadiazole derivatives. The problem he aims to solve is the need for a new antibiotic that exhibits strong antibacterial activity against both sensitive and resistant bacteria. This antibiotic also possesses excellent solubility and a safety profile suitable for human use. Through intensive research, Konosu and his team discovered a compound represented by a specific general formula that meets these criteria. Another significant patent involves an Imidazole carbonyl compound, which aims to develop an antibiotic with a novel mechanism of action. This compound is characterized by weak cytotoxicity, high solubility in water, and the ability to inhibit both DNA gyrase GyrB and topoisomerase IV ParE subunits, demonstrating sufficient antibacterial activity.
Career Highlights
Throughout his career, Toshiyuki Konosu has worked with notable companies such as Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His innovative research has led to advancements in antibiotic development, making a substantial impact on public health.
Collaborations
Konosu has collaborated with esteemed colleagues, including Sadao Oida and Takuya Uchida. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.
Conclusion
Toshiyuki Konosu's work in antibiotic innovation highlights the importance of addressing bacterial resistance and improving treatment options. His contributions continue to shape the future of pharmaceutical research and development.